90
Participants
Start Date
October 16, 2019
Primary Completion Date
January 18, 2021
Study Completion Date
June 7, 2021
Apremilast
Apremilast
Placebo
Placebo
Research Site, Ichinomiya
Research Site, Nagoya
Research Site, Fukuoka
Research Site, Sapporo
Research Site, Hitachi
Research Site, Sagamihara-shi
Research Site, Yokohoma-shi
Research Site, Yokosuka
Research Site, Izumo
Research Site, Chiyoda-ku
Research Site, Itabashi-ku
Research Site, Itabashi-ku
Research Site, Kisarazu
Research Site, Kofu
Research Site, Minokamo
Research Site, Nankoku-shi
Research Site, Osaka
Research Site, Sendai
Research Site, Shinjuku-ku
Research Site, Shinjyuku-ku
Research Site, Tōon
Research Site, Tsu
Lead Sponsor
Amgen
INDUSTRY